Cargando…
P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430530/ http://dx.doi.org/10.1097/01.HS9.0000972016.06838.fa |
_version_ | 1785090986229104640 |
---|---|
author | Medinger, Michael Passweg, Jakob Bucher, Christoph Finke, Juergen Schanz, Urs Stylianou, Christos Dertschnig, Simone Souquières, Malika Oehen, Stephan Kueenburg, Elisabeth Heim, Dominik |
author_facet | Medinger, Michael Passweg, Jakob Bucher, Christoph Finke, Juergen Schanz, Urs Stylianou, Christos Dertschnig, Simone Souquières, Malika Oehen, Stephan Kueenburg, Elisabeth Heim, Dominik |
author_sort | Medinger, Michael |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430530 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104305302023-08-17 P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION Medinger, Michael Passweg, Jakob Bucher, Christoph Finke, Juergen Schanz, Urs Stylianou, Christos Dertschnig, Simone Souquières, Malika Oehen, Stephan Kueenburg, Elisabeth Heim, Dominik Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430530/ http://dx.doi.org/10.1097/01.HS9.0000972016.06838.fa Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Medinger, Michael Passweg, Jakob Bucher, Christoph Finke, Juergen Schanz, Urs Stylianou, Christos Dertschnig, Simone Souquières, Malika Oehen, Stephan Kueenburg, Elisabeth Heim, Dominik P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
title | P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
title_full | P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
title_fullStr | P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
title_full_unstemmed | P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
title_short | P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION |
title_sort | p1282: mocravimod improves overall survival in aml patients undergoing allogeneic hematopoietic cell transplantation |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430530/ http://dx.doi.org/10.1097/01.HS9.0000972016.06838.fa |
work_keys_str_mv | AT medingermichael p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation AT passwegjakob p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation AT bucherchristoph p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation AT finkejuergen p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation AT schanzurs p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation AT stylianouchristos p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation AT dertschnigsimone p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation AT souquieresmalika p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation AT oehenstephan p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation AT kueenburgelisabeth p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation AT heimdominik p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation |